The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The C14H21N3O2S Drug Master File in Japan (C14H21N3O2S JDMF) empowers C14H21N3O2S API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the C14H21N3O2S JDMF during the approval evaluation for pharmaceutical products. At the time of C14H21N3O2S JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of C14H21N3O2S suppliers with JDMF on PharmaCompass.